Regarding Kuldorffs qualifications
Martin Kulldorff, PhD, weighs in. Dr. Kulldorff also presents a balanced picture of where Sweden made mistakes in their response.
From ContagionLive
Kulldorff is a biostatistician in the Division of Pharmacoepidemiology and Pharmacoeconomics at the Brigham and Women’s Hospital + Harvard Medical School. He has long been working in infectious disease outbreaks, detection of new disease outbreaks, and developing novel epidemiological methods.
He has developed new sequential statistical methods for near real-time post-market drug and vaccine safety surveillance, where the purpose is to use weekly, monthly or other frequent data feeds to find potential safety problems as soon as possible.